Natus Medical Inc (BABY) is Initiated by The Benchmark Company to Buy, Price Target at $55

Natus Medical Inc (BABY) was Initiated by The Benchmark Company to “Buy” and the brokerage firm has set the Price Target at $55. The Benchmark Company advised their investors in a research report released on Oct 4, 2016.

Many Wall Street Analysts have commented on Natus Medical Inc. Natus Medical Inc was Upgraded by Raymond James to ” Outperform” on Sep 13, 2016.

On the company’s financial health, Natus Medical Inc reported $0.39 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Jul 20, 2016. Analyst had a consensus of $0.36. The company had revenue of $96.00 million for the quarter, compared to analysts expectations of $92.71 million. The company’s revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.34 EPS.

Natus Medical Inc opened for trading at $39.26 and hit $39.52 on the upside on Friday, eventually ending the session at $39.29, with a gain of 0.64% or 0.25 points. The heightened volatility saw the trading volume jump to 4,75,866 shares. Company has a market cap of $1,295 M.

In a different news, on Sep 28, 2016, James B Hawkins (CEO) purchased 10,000 shares at $38.48 per share price. According to the SEC, on Apr 28, 2016, Robert A Gunst (director) sold 5,000 shares at $34.61 per share price. On Apr 28, 2016, Doris Engibous (director) sold 5,000 shares at $32.68 per share price, according to the Form-4 filing with the securities and exchange commission.

Natus Medical Incorporated (Natus) is a provider of newborn care and neurology healthcare products and services used for the screening diagnosis detection treatment monitoring and tracking of common medical ailments in newborn care hearing impairment neurological dysfunction epilepsy sleep disorders and balance and mobility disorders. The Company offers two product families: Neurology which includes products and services for diagnostic electroencephalography and long term monitoring intensive care unit monitoring electromyography sleep analysis intra-operative monitoring and diagnostic and monitoring transcranial doppler ultrasound technology; and Newborn Care which includes products and services for newborn care including hearing screening brain injury thermoregulation jaundice management and various disposable products as well as products for diagnostic hearing assessment for children through adult populations and others.

Natus Medical Inc

Leave a Reply

Natus Medical Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Natus Medical Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.